Fig. 2From: Prognostic significance of T lymphocyte subgroups (CD4 and CD8) in lung cancer patients after neoadjuvant chemotherapya + b. CD4 staining intensities in a case diagnosed with squamous cell carcinoma receiving neoadjuvant therapy(CD4, x200), c + d. CD8 staining intensities in cases diagnosed with squamous cell carcinoma receiving neoadjuvant therapy(CD8, x200)Back to article page